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The synucleins (, , and ) are highly homologous proteins thought to play a role in regulating neurotransmission and are found
abundantly in presynaptic terminals. To overcome functional overlap between synuclein proteins and to understand their role in pre-
synaptic signaling from mesostriatal dopaminergic neurons, we produced mice lacking all three members of the synuclein family. The
effect on the mesostriatal system was assessed in adult (4- to 14-month-old) animals using a combination of behavioral, biochemical,
histological, and electrochemical techniques. Adult triple-synuclein-null (TKO)mice displayed no overt phenotype and no change in the
number ofmidbrain dopaminergic neurons. TKOmice were hyperactive in novel environments and exhibited elevated evoked release of
dopamine in the striatum detected with fast-scan cyclic voltammetry. Elevated dopamine release was specific to the dorsal not ventral
striatum and was accompanied by a decrease of dopamine tissue content. We confirmed a normal synaptic ultrastructure and a normal
abundance of SNARE (solubleN-ethylmaleimide-sensitive factor attachment protein receptor) protein complexes in the dorsal striatum.
Treatment of TKO animals with drugs affecting dopamine metabolism revealed normal rate of synthesis, enhanced turnover, and
reduced presynaptic striatal dopamine stores. Our data uniquely reveal the importance of the synuclein proteins in regulating neu-
rotransmitter release from specific populations of midbrain dopamine neurons throughmechanisms that differ from those reported in
other neurons. The finding that the complete loss of synucleins leads to changes in dopamine handling by presynaptic terminals specif-
ically in those regions preferentially vulnerable in Parkinson’s disease may ultimately inform on the selectivity of the disease process.
Introduction
-Synuclein is central to the etiology of Parkinson’s disease (PD),
a neurodegenerative condition in which dopaminergic neurons
projecting from the substantia nigra pars compacta (SNpc) to the
dorsal striatum are particularly vulnerable (Goedert, 2001; Tro-
janowski and Lee, 2002). -Synuclein has long been associated
with PD neuropathology and the familial forms of the disease, and
more recent genome-wide association studies implicate variation in
-synuclein as an etiological factor in idiopathic forms of PD and
other synucleinopathies (Mizuta et al., 2008; Pankratz et al., 2009;
Satake et al., 2009; Scholz et al., 2009; Simo´n-Sa´nchez et al., 2009).
Given this strong association with disease, it is essential that
we understand the roles of -synuclein in the normal function of
dopaminergic neurons to learn how -synuclein dysfunction
contributes to neurodegeneration. -Synuclein has been shown
to play a role in many processes important to synaptic dopamine
turnover (for review, see Venda et al., 2010). Much of the exper-
imental evidence has, however, been obtained in vitro or in cul-
tured cells (Jenco et al., 1998; Perez et al., 2002; Wersinger and
Sidhu, 2003; Peng et al., 2005; Larsen et al., 2006; Tehranian et al.,
2006; Fountaine et al., 2008; Liu et al., 2008), and similar roles
have yet to be identified in the adult brain where normal connec-
tivity is preserved. Moreover, studies of neurotransmitter release
in knock-out (KO) and transgenic mice or primary neurons ob-
tained from these animals have produced conflicting data about
the role of normal or mutated -synuclein (Abeliovich et al.,
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2000; Cabin et al., 2002; Chandra et al., 2004; Liu et al., 2004;
Yavich et al., 2004, 2005; Unger et al., 2006; Senior et al., 2008;
Garcia-Reitbo¨ck et al., 2010; Nemani et al., 2010; Scott et al., 2010).
The high level of similarity in amino acid sequence, over-
lapping expression patterns, and abundance of all three sy-
nucleins in presynaptic terminals suggest the potential for
functional overlap. Compensatory function is supported by
increased expression of the remaining family member in the
CNS of /-synuclein and /-synuclein double-KO mice
(Chandra et al., 2004; Robertson et al., 2004). Moreover, de-
velopment of pathology in cysteine string protein (CSP)-KO
mice is accelerated in the absence of both - and -synuclein
to a greater extent than in the absence of either alone (Chandra
et al., 2005), further arguing for overlapping function of sy-
nuclein family members.
To better understand the role of the synucleins in dopamine
neurotransmission and to overcome compensatory changes and
functional overlap, we produced synuclein-freemice and studied
the outcome on the function of mesostriatal neurons. In the ni-
grostriatal system of triple-synuclein-null (TKO)mice, we reveal
substantial changes in synaptic dopamine neurotransmission,
but no overt structural alterations in the dopaminergic neurons
or their synapses. Moreover, we identify that the effect of deple-
tion of all synucleins on dopamine transmission is specific to the
dorsal but not ventral striatum,which correlateswith the regional
vulnerability in PD. Our data point to the unique importance of
the synucleins to the nigrostriatal system, consistent with associ-
ation of -synuclein to PD.
Materials andMethods
Generation of double- and triple-synuclein-null mutant animals
Generation of /-synuclein double-KO mice on C57BL/6J (Charles
River) background was described previously (Robertson et al., 2004).
Heterozygous -synuclein-KOmice (Chandra et al., 2004) on C57BL/6J
background were further backcrossed with C57BL/6J (Charles River)
mice for six generations in Cardiff University Transgenic Animal Unit
before breeding with /-synuclein double-KO mice. Resultant triple-
heterozygous animals were intercrossed to produce founders of
triple-KO and wild-type colonies used in this study. Thus, all studied
animals were on the same C57BL/6J genetic background. If not stated
otherwise, 4- to 5-month-old male mice were used in experiments. In-
vestigators who performed behavioral and postmortem analyses were
blinded with respect to the sample genotype. All animal work was per-
formed in accordance with theUnited KingdomAnimals (Scientific Pro-
cedures) Act (1986).
Behavioral analyses
Balance and coordination of experimental animals were analyzed using
static rods and accelerating rotarod tests. Locomotor activity was mea-
sured in the home cage or nonanxiogenic open field. Spontaneous alter-
nation in a T-maze, elevated plusmaze, holeboard, and bright open-field
tests were used to assess animal anxiety and exploratory behavior. The
above methods were described in our previous publications (Robertson
et al., 2004; Senior et al., 2008).
Inverted grid test. Mice were placed onto a 30  30 cm square mesh
consisting of 5 mm squares of 0.5-mm-diameter wire. The grid was
slowly rotated to the inverted position and held above a thick layer of
beddingmaterial. If a mouse fell from the grid earlier than themaximum
test time of 1 min, the latency to fall was noted and after a 10 min rest in
the home cage, the test was repeated. The best result from three attempts
was included in the statistics.
Activity camera. Animals were moved to the testing room 30 min
before the start of the test. The lighting in the test room was the same as
in the animal holding room. Each animal was placed in an individual
transparent 40 40 cm Perspex box equipped with a system of infrared
beams to monitor activity (Ugo Basile). Data (number of beam breaks)
were collected at 4 min intervals for 2 h.
Climbing test. Animals injected with 4 mg/kg apomorphine were
placed in 12-cm-diameter cylindrical individual cages with walls of ver-
tical, 2-mm-diameter, 1-cm-apart metal bars as described previously
(Protais et al., 1976) and filmed for 90 min. Climbing was scored con-
stantly and expressed as the number of seconds within each 4 min inter-
val that an animal spent with forefeet holding the cage wall bars plus
double the number of seconds when all four paws were holding the wall
bars.
Pharmacological treatments
All drug solutions for injections were freshly prepared. 3-Hydroxy-
benzylhydrazine (NSD-1015), methyl L-3,4-dihydroxyphenylalanine
(L-DOPA), cocaine, and D-amphetamine (dAMPH) (all from Sigma-
Aldrich) were dissolved in sterile 0.9% saline and apomorphine in sterile
0.1% ascorbic acid/0.9% saline. Five or 10 ml/kg of a drug solution or
vehicle were injected intraperitoneally or subcutaneously as indicated.
Cocaine and amphetamine. Thirty minutes after placement in the ac-
tivity camera, animals received a single intraperitoneal injection of 10
mg/kg cocaine or 4 mg/kg D-amphetamine and were immediately re-
turned into the same camera for an additional 90 min of activity
recording.
L-DOPA. After accommodation in the testing room for 20 min, ani-
mals received a single intraperitoneal injection of 50 mg/kg methyl
L-DOPA hydrochloride and were returned to the home cage. Twenty
minutes after injection, animals were placed into the activity camera for
activity testing and amphetamine injections that were performed exactly
as described above.
Apomorphine. For subcutaneous injections, apomorphine was dis-
solved at a concentration of 0.4 mg/ml. Animals that received 4 mg/kg
apomorphine were analyzed for climbing behavior as described above.
NSD-1015.Tomeasure the in vivo rate of dopamine biosynthesis,mice
were injected intraperitoneally with 100 mg/kg NSD-1015 (Carlsson et
al., 1972). The dorsal striata were dissected from animals killed 40 min
after the injection, and the level of accumulated L-DOPAwas determined
by HPLC analysis as described below.
Biochemical analysis
Protein extraction andWestern blotting were performed as described in
our previous publications (Buchman et al., 1998; Robertson et al., 2004;
Al-Wandi et al., 2010). Coimmunoprecipitation of soluble N-ethyl-
maleimide-sensitive factor attachment protein receptor (SNARE) pro-
teins was performed as described previously (Burre´ et al., 2010). Primary
antibodies and dilutions are listed in a table (see Notes). For detection of
protein bands on Western blots, fluorescently labeled (Cy3 or Cy5) sec-
ondary antibodies and the FluorChem Q MultiImage III system (Alpha
Innotech) were used. Band intensities were quantified using FluorChem
Q, version 1.3.0, analysis software. Relative concentrations of each pro-
tein in analyzed samples were calculated after normalizing band intensi-
ties against intensities of housekeeping protein (-actin, -tubulin, or
GAPDH) bands.
Monoamines weremeasured byHPLCwith electrochemical detection
as described previously (Senior et al., 2008; Al-Wandi et al., 2010) using
a 4.6  150 mm Microsorb C18 reverse-phase column (Varian) and
Decade II ECD with a Glassy carbon working electrode (Antec Leyden)
set at0.7 V with respect to a Ag/AgCl reference electrode. For measur-
ing dopamine and its metabolites, the mobile phase consisted of 12%
methanol (v/v), 0.1 Mmonosodiumphosphate, 2.4mM 1-octane sulfonic
acid (OSA), 0.68 mM EDTA, pH 3.1. For L-DOPA, a mobile phase of the
same composition but containing 0.4 mM OSA was used.
Immunohistochemistry and neuronal cell counts
Fixation, processing, embedding, preparing of microtome sections, and
their immunostaining were performed as in our previous studies (Buch-
man et al., 1998; Robertson et al., 2004; Ninkina et al., 2009; Al-Wandi et
al., 2010). Primary antibodies and dilutions are listed in a table (see
Notes). Stereological counting of neurons was performed as previously
described for single- and double-synuclein-KO mice (Ninkina et al.,
2003; Robertson et al., 2004; Al-Wandi et al., 2010).
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Fast-scan cyclic voltammetry
Ten- to 14-month-old mice were killed by cervical dislocation and de-
capitated, and their brains were removed over ice. Three hundred fifty
micrometer coronal striatal slices were cut using a vibratome (Leica Mi-
crosystems) in ice-cold HEPES-buffered physiological saline saturated
with 95% O2/5% CO2 and maintained in a bicarbonate-buffered artifi-
cial CSF (containing 2.4mMCa2) as described previously (Cragg, 2003;
Rice and Cragg, 2004). Extracellular dopamine concentration was mon-
itored and quantified in the dorsal and ventral striatum at 32°C using
fast-scan cyclic voltammetry (FCV) as previously described (Cragg,
2003) with 10-m-diameter carbon-fiber microelectrodes (exposed tip
length, 50–100 m, fabricated in-house) and a Millar voltammeter
(Julian Millar, Barts and The London School of Medicine and Dentistry,
London, UK). The applied voltage was a triangular waveform, with a
voltage range of0.7 to 1.3 to0.7V versusAg/AgCl at a scan rate of 800
V/s. The sampling frequency was 8 Hz. Data were acquired and analyzed
using Strathclyde Whole Cell Program (University of Strathclyde, Glas-
gow, UK). Electrodes were positioned in striatal slices to a depth of 100
m. The evoked current signal was confirmed as dopamine by compar-
ing the potentials for peak oxidation and reduction currents with those of
dopamine in calibration media (500–600 and 200 mV vs Ag/AgCl,
respectively). Electrodes were calibrated in 1–2 M dopamine in experi-
mental media. Dopamine release was evoked by a surface, concentric
bipolar Pt/Ir electrode (25 m diameter; FHC) as described previously
(Rice and Cragg, 2004). Stimulus pulses generated out-of-phase with
FCV scans andwere applied at the lowest current that generatedmaximal
dopamine release with a single stimulus pulse in wild-type animals (650
A, 200 s pulse duration).
FCV experiments assessed extracellular dopamine concentration
([DA]o) evoked by discrete stimuli in the caudate–putamen (CPu) and
nucleus accumbens (NAc). Recording sites classed as CPu were located
dorsal to the anterior commissure (AC); NAc was ventral to the AC.
Data were collected through one of two experimental designs. First,
several sites were sampled per slice (six to eight CPu, four NAc) in both
genotypes on the same experimental day. Stimuli in these experiments
consisted of either a single pulse or burst pulses (four pulses at 100 Hz).
In the second stimulation paradigm, recordings were taken at a single
recording site at 2.5 min intervals, to ensure consistent release, and con-
sisted of either single pulses or trains of five pulses at at a range of fre-
quencies (1–100 Hz) in randomized order. These frequencies span the
full range of dopaminergic neuron firing frequencies reported in vivo.
For these experiments in CPu, recording sites were in the dorsal half of
the nucleus.Data aremeans SEM, and the sample size,n, is the number
of observations. The number of animals in each data set was3. Com-
parisons for differences inmeans were assessed by one-way ANOVA and
post hoc Bonferroni’s multiple-comparison t test or unpaired t test using
GraphPad Prism.
Dopamine uptake was assessed by comparing the decay phases of do-
pamine transients evoked by a single pulse between the two genotypes.
Dopamine transients were concentrationmatched for a peak of 1.0 0.1
M from five animals in each genotype. Dopamine uptake via dopamine
active transporter (DAT) is the principal factor governing dopamine
decay in these evoked transients (Giros et al., 1996). The rate of dopa-
mine uptake by theDATobeysMichaelis—Menton kinetics and is there-
fore proportional to Vmax and varies with [DA]o. Comparison of the
decay phase of dopamine transients matched for similar peak [DA]o
eliminates differences in uptake rate caused by differences in [DA]o;
therefore, prevailing differences inVmax should be apparent (Cragg et al.,
2000).
Electron microscopy
Sample preparation.Mice were terminally anesthetized and perfuse-fixed
with 4% paraformaldehyde and 0.1% glutaraldehyde. Sagittal vibratome
sections (60 m) were incubated in a primary antibody against tyrosine
hydroxylase (TH), and dopaminergic axons were revealed using either
silver-intensified immunogold particles or a peroxidase reaction using
diaminobenzidine (DAB) as the chromogen (Moss andBolam, 2008). All
sectionswere thenwashed three times in 0.1 M phosphate buffer (PB), pH
7.4. The sections were postfixed in 1% osmium tetroxide in PB (Oxkem)
for either 7min (immunogold) or 40min (DABperoxidase). After wash-
ing in 0.1 M PB, sections were dehydrated in an ascending series of etha-
nol dilutions [15 min in 50% ethanol, 35 min in 70% ethanol, which
included 1%uranyl acetate (TAAB), 15min in 95% ethanol, and twice 15
min in absolute ethanol]. After absolute ethanol, sections were washed
twice in propylene oxide (Sigma-Aldrich) for 15 min, placed into resin
(Durcupan ACM; Fluka), and left overnight (15 h) at room tempera-
ture. The resin was thenwarmed to reduce its viscosity, and sections were
placed on microscope slides, a coverslip applied, and the resin cured at
65°C for70 h.
Electron-microscopic analysis. All sections were examined in the light
microscope and areas from the dorsolateral striatum were cut from the
slide, glued to the top of a resin block, and trimmed with razor blades.
Serial sections, 50 nm thick (gray/silver), were cut using an ultrami-
crotome (Leica EM UC6; Leica Microsystems), collected on pioloform-
coated, single-slot copper grids (Agar Scientific), and lead-stained to
improve contrast for electron-microscopic examination. APhilipsCM10
electron microscope was used to examine the sections. Analyses of
preembedding immunogold sections were performed at aminimumof 5
m from the tissue–resin border (i.e., the surface of the section). The
maximum distance from the tissue–resin border examined was deter-
mined by the penetration of the gold conjugated antibody together with
the angle at which the tissue–resin was sectioned, and was therefore
variable.
For both immunogold and peroxidase-labeled tissue, TH-positive
structures were systematically analyzed in one of the serial sections on an
electron-microscopic grid. At a magnification at which it is not possible
to clearly visualize synapses (1950), an area was chosen at random, the
magnification was then increased (25,000), and the first structure pos-
itively labeled for THwas digitally recorded at an indicatedmagnification
of 36,500 (Gatan multiscan CCD camera; Gatan). TH-positive struc-
tures were identified and imaged, in this way, continuing systematically
in straight lines across the section, keeping the identified TH-positive
structure central within the image frame. For immunogold-labeled
structures, the criterion for an immunopositive structure was five or
more silver-intensified immunogold particles. This systematic process
was continued within the same section until 25 TH-positive structures
were identified and imaged, the process was then repeated using a differ-
ent section on a different grid until 50 TH-immunopositive structures
were identified and imaged per animal for both immunogold labeled
tissue (150 images in total) and peroxidase-labeled tissue (150 images in
total). Symmetric synapses (Gray’s type II) were identified by the pres-
ence of presynaptic and postsynaptic membrane specializations, a wid-
ened synaptic cleft and cleft material. Any structures seen to be forming
such symmetric synapses were imaged at a higher magnification of
46,500.
Quantitative EM image analysis. Digital images were analyzed using
the publicly available software ImageJ (http://rsbweb.nih.gov/ij/) and the
ImageJ plug-ins PointDensity and PointDensitySyn (http://folk.uio.no/
maxdl/software.html) (Larsson and Broman, 2005). Images were ad-
justed for contrast and brightness usingAdobe Illustrator andPhotoshop
(version CS3; Adobe Systems).
For analysis of TH-positive (peroxidase-labeled) structures, the
central TH-positive structure within the image frame was analyzed by
tracing the perimeter, the number of mitochondria within the profile
was counted, and if the structure was forming a synaptic specializa-
tion, then the length of the active zone(s) was measured. The active
zone was defined as the length of plasma membrane opposing the
postsynaptic density, across the synaptic cleft. Other TH-positive
structures completely within the electron micrograph frame were
counted. Analysis of immunogold-labeled TH-positive structures was
performed using PointDensity, the perimeter of the central structure
within the frame was delineated, and then a point marker was placed
within the center of each vesicle. Vesicles were marked if at least 50%
of the vesicle membrane was visible. All other TH-positive profiles
within the frame were counted. TH-positive profiles that were form-
ing synapses were analyzed using PointDensitySyn, the plasma mem-
brane of the structure was traced, the active zone(s) were delineated,
and points were placed in the center of the vesicles.
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Statistical analysis
All data are presented as means  SEM. Statistical analysis was per-
formedusing SPSS/PASWStatistics, versions 16.0 or 18.0 (SPSS),Graph-
Pad Prism 4.0 (GraphPad Software), and GB-Stat PPC 6.5.4 (Dynamic
Microsystems).
Results
Geneneration of TKO mice
At all stages of the breeding program (see Materials and Meth-
ods), an expected Mendelian frequency of TKO mice on pure
C57BL/6J genetic background was observed in weaned litters.
TKO mice, studied up to 14 months of age, were phenotypically
indistinguishable from wild-type mice generated within the
same breeding program and no differences in size, weight, or
gross anatomy of the brain of TKO and wild-type mice were
observed.
Because of the well known links be-
tween -synuclein and dopamine dys-
function in Parkinson’s disease, and the
prominent expression and presynaptic lo-
calization of all three synuclein family
members in dopaminergic neurons of the
SNpc [data are available (see Notes)]
(Abeliovich et al., 2000), we performed
in-depth studies on the midbrain dopa-
minergic systems of TKO mice.
Normal numbers of dopaminergic
neurons in the SNpc and normal
expression of synaptic markers in the
striatum of TKOmice
Stereological counts ofmidbrain dopami-
nergic neurons, identified by immuno-
staining for TH, revealed no difference in
the number of neurons in the SNpc and
ventral tegmental area (VTA) of TKO
mice compared with wild-type mice (Fig.
1A). Immunostaining of the striatum
with markers of dopaminergic terminals,
TH or DAT (Fig. 2A), or general synaptic
marker synapsin IIa (Fig. 2B), and quan-
titative Western blot analysis of striatal
tissue proteins (Fig. 2C) [quantification of
data is available (see Notes)] also revealed
no differences in morphology or levels of
all studied synaptic markers.
Decreased levels of dopamine and its
metabolites in the striatum of
TKO mice
HPLC analysis of tissue monoamines re-
vealed that the dopamine content in the
dorsal striatum of 4-month-old male
TKO mice was substantially decreased
compared with wild-type animals (Fig.
1B). The levels of the major dopamine
metabolites, 3,4-dihydroxyphenylacetic
acid (DOPAC) and homovanillic acid
(HVA), were less affected, resulting in in-
creases of DOPAC/dopamine and HVA/
dopamine ratios (Fig. 1B) [additional
data are available (see Notes)]. To deter-
mine whether decreased striatal dopa-
mine level in mutant mice is a
consequence of reduced activity of TH, the rate-limiting enzyme
in dopamine synthesis, we inhibited aromatic L-amino acid de-
carboxylase (AADC), the enzyme immediately downstream of
TH in the synthetic pathway, by treating mice with NSD-1015.
Striatal extracts were prepared 45min after intraperitoneal injec-
tion of 100 mg/kg of the inhibitor, and the level of L-DOPA was
assessed by HPLC. No difference in L-DOPA accumulation,
which is an indicator of in vivo TH activity, was found between
wild-type and TKO mice (Fig. 1C). Together, these data suggest
that, in the absence of neuronal loss or obvious biochemical or
morphological changes of dopaminergic synapses [also con-
firmed by electron microscopy analysis (see below)], TKO mice
display signs of synaptic dysfunction in the nigrostriatal system at
the level of regulation of dopamine availability. Therefore, we
studied performance of TKOmice in behavior tests, the results of
Figure 1. Triple-synuclein-null mutant mice possess a normal complement of dopaminergic neurons in the SNpc and VTA,
normal rate of in vivo TH activity, but reduced level of dopamine and its metabolites in the striatum. A, The bar charts show
means  SEM of total number of TH-positive neurons in SNpc and VTA of 4-month-old wild-type (WT) (n  18) and TKO
(///) (n 28)mice. Neuronswere stereologically counted separately in the left and right structures.B, Striatal
concentrations (picomolespermilligramofprotein) of dopamine (DA)and itsmetabolites, DOPACandHVA,werenormalized to the
mean value for wild-type animals (100%). Means  SEM of data obtained from 15 wild-type (WT) and 14 TKO (//
/) mouse samples are shown (**p 0.01; Kolmogorov–Smirnov test). For metabolite/dopamine ratios, see table (see
Notes). C, The rate of L-DOPA accumulation in the striatum of wild-type (WT) (n 5) and TKOmice (///) (n
5) after intraperitoneal injection of 100 mg/kg AADC inhibitor NSD-1015.
Figure 2. Normal morphology and expression of synaptic markers in the striatum of triple-synuclein-null mutant mice. A, TH
and DAT expression in the striatum of 4-month-oldmice. Representative microphotographs of coronal sections of wild-type (WT)
and TKO (///) mouse brains at the bregma 0.38 mm level. Scale bar, 1 mm (for all images). B, High-
magnification confocal images of striatal sections immunofluorescently stained with antibodies against synapsin IIa. Scale bar, 2
m (for both images). C, Western blot analysis of proteins in the striatum of wild-type andmutantmice. RepresentativeWestern
blots show analysis of striatal samples from twomice for each genotype.
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which might be affected by alterations in
dopamine neurotransmission.
Hyperdopaminergic-like behavior of
TKO mice
The inverted grid and static rods tests
were used to assess balance and coordina-
tion of 4-month-old TKO mice. The per-
formance of both male and female adult
mutant mice was very similar to the per-
formance of age/gender-matched wild-
type mice (Fig. 3A) [additional data are
available (see Notes)]. However, aging
mutant mice gradually lose the ability to
stay on the inverted grid (Fig. 3A). In con-
trast, the accelerated rotarod test, inwhich
the animal’s endurance capacity affects
the results, revealed significantly compro-
mised performance of TKO mice already
at the age of 4 months (Fig. 3B).
Wild-type and TKO animals behaved
in a similar manner in the bright open-
field and elevated plusmaze tests [data are
available (see Notes)], suggesting that the
lack of synucleins does not affect mouse
anxiety.
Several tests revealed significant differ-
ences in the activity in novel nonanx-
iogenic environment and exploratory
behavior of wild-type and TKO mice. In
the nonanxiogenic open field, mutant
mice were more active (Fig. 3D) and
reared more often (Fig. 3E). In the hole-
board test, the number of nose pokes into
holes was significantly greater for mutant
than wild-type mice (Fig. 3F,G), suggest-
ing increased overall exploratory behav-
ior. TKOmice also showed a trend toward
a decreased spontaneous alternation in a
T-maze (Fig. 3C). Finally, monitoring of
animal activity in the home-like cage
demonstrated that TKO mice respond to
changes in the environment with a sub-
stantially greater increase in locomotion
than wild-type mice (Fig. 3H). However,
after adaptation to the new environment, the locomotor activity
of mice was similar for both genotypes (Fig. 3I).
Increased levels of electrically evoked dopamine in the dorsal
striatum of TKO mice
Together, these data suggest that, despite a decrease in striatal
dopamine levels, TKOmice exhibit behavior typical of hyperdo-
paminergic animals (Zhuang et al., 2001), suggesting that synap-
tic mechanisms regulating dopamine release or uptake might be
modified in the absence of synucleins. We used FCV at carbon-
fiber microelectrodes to assess subsecond release and uptake of
dopamine in the dorsal (CPu) and ventral (NAc) striatum.
In theCPu,meanpeak extracellular concentrationsofdopamine
([DA]o)evokedby singlepulsesorburst stimuli (fourpulses, 100Hz)
across a large number of recording sites were 1.5-fold greater in
TKO than wild-type mice (Fig. 4A,B) [additional data are available
(see Notes)]. By contrast, in the NAc no difference in evoked [DA]o
was detected between the two genotypes (Fig. 4D) [additional data
are available (see Notes)]. The frequency dependence of dopamine
release at given recording sites assessedacross a full rangeof frequen-
cies observed fordopaminergic neurons in vivo (1–100Hz)was sim-
ilar in both genotypes (Fig. 4C) [additional data are available (see
Notes)] and consistent with previous observations in CPu and
NAc (Exley et al., 2008). Analysis by HPLC of dopamine content
inCPu andNAc subdissected from slices used for FCV confirmed
that dopamine content in CPu was 30% lower in triple-
synuclein-null mice (Fig. 4E; as seen in fresh tissue, Fig. 1B) and
identified that, in the NAc, dopamine content was not different
between genotypes (Fig. 4F).
Increased evoked dopamine in the dorsal striatum is not
attributable to differences in nicotinic receptor function or
the Ca2 dependence of release
Since in CPu of TKO mice, dopamine content is two-thirds of
wild type, but release is 1.5-fold greater, deletion of all three
synucleins results in a2-fold increase in the releasability of the
available dopamine. Because striatal acetylcholine (ACh) is a crit-
Figure 3. Performance of wild-type and triple-synuclein-null mutant mice in balance/coordination and exploratory behavior
tests and their activity in novel nonanxiogenic environment. The bar charts showmeans SEM of experimental values obtained
by testing wild-type (WT) and TKO (///) mice. For all panels, the number of animals tested and, where appro-
priate, a statistically significant difference are shown (*p 0.05; **p 0.01; Kolmogorov–Smirnov test). A, The latency to fall
from the inverted grid of male 2-year-old wild-type and mutant mice of various ages. The number of animals that successfully
completed the task at least once from three attempts is shown for each experimental group (in brackets). The best result for each
mouse was used for calculating the groupmean.B, The latency to fall from the accelerating rotarod of 4-month-oldmalemice. C,
Percentageof trials inwhich4-month-old femalemice alternated in a T-maze. Thedifferencebetweengroups reached significance
( p 0.037) only when less robust Mann–Whitney test but not Kolmogorov–Smirnov test was used. The number of squares
4-month-old female mice entered (D) and the number of rears (E) during 3 min testing in nonanxiogenic open field. The number
of nose pokes into peripheral (F ) and central (G) holes during 3 min assessing of 4-month-old female mice in the holeboard test.
H, I, The locomotor activity (number of infrared beam breaks) of 4-month-old male wild-type (white diamonds; n 13) and
mutant (gray squares; n 13) mice in a home-like cagemonitored for 28 h. Total number of breaks for each 1 h interval (H ) and
for the first or last 4 h intervals (I ), both corresponding to 10:00 A.M. to 2:00 P.M., are shown. Note that a sharp increase of animal
activity during the 10th interval was triggered by switching off the room light.
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ical regulator of dopamine release probability, we assessed how
dopaminergic synapses of TKO mice perform independently of
ACh input. The nicotinic acetylcholine receptor (nAChR) antag-
onist dihydro--erythroidine hydrobromide (DHE) modified
evoked [DA]o in a frequency-dependentmanner (Fig. 5A,B), but
similarly in both genotypes. Furthermore, in the absence of
nAChR activity, the underlying range of [DA]o released by four
pulses (4p) at 100Hz versus 1Hz was an approximately threefold
to fourfold range in both genotypes (Fig. 5A,B), consistent with a
similar release probability in both genotypes. Therefore, the ob-
served increase in dopamine releasability in CPu of triple-
synuclein-null mice is not readily attributable to an upregulation
of either nAChR function or underlying dopamine release
probability.
We assessedwhether the higher evoked [DA]o despite reduced
dopamine content in CPu of triple-synuclein-null mice may be
caused by a modified sensitivity of the exocytotic machinery to
calcium. Varying extracellular calcium (in the presence of DHE
to eliminate confounding effects on Ca2-dependent ACh re-
lease) modified [DA]o evoked by a single pulse in both genotypes
as predicted, but in a manner that was not significantly different
(Fig. 5C). Furthermore, the ratio of [DA]o evoked by a burst
(4p/100 Hz) versus one pulse (4p:1p) decreased as expected with
increasing [Ca2]o but with no difference between genotypes
(Fig. 5C), indicating no difference in the relative probability of
dopamine release between genotypes.
Increased levels of evoked dopamine in the dorsal striatum is
not attributable to differences in uptake of dopamine
Functional interactions between -synuclein and DAT have
been suggested previously (Lee et al., 2001; Wersinger and
Sidhu, 2003; Fountaine et al., 2008). Therefore, we investi-
gated whether higher evoked [DA]o in TKO mice could be
attributed to lower dopamine uptake. In extracellular dopa-
mine transients that were matched for peak [DA]o (1.0  0.1
M), the decay rate was similar in each genotype (Fig. 5D).
Because the decay phase of the dopamine transients is a func-
tion of dopamine uptake by DAT, this suggests that the rate of
reuptake was not different in TKO mice compared with wild-
type control mice.
Attenuated responses of TKOmice to psychostimulants
Our studies of TKO mice revealed a paradoxical combination of
reduced striatal dopamine content but a hyperdopaminergic
Figure 4. Electrically evoked dopamine transients and regulation of dopamine signals by
firing frequency in wild-type and triple-synuclein-null mutant mice measured by FCV. A, Mean
profiles of [DA]o versus time (mean SEM) after a single pulse (0.2s; arrow) in the dorsal
striatum (CPu). In CPu, peak [DA]o transiently evoked by single pulses is greater in triple-
synuclein-null mutant (///) than wild-type (WT) mice [***p 0.001, one-
way ANOVA; WT, n 81; ///, n 86 (5 animals for each genotype)]. B,
Histogram of peak [DA]o of evoked dopamine transients in the CPu in wild-type versus triple-
synuclein-null mutant mice for individual sampling sites. C, Mean peak [DA]o SEM versus
frequency during five-pulse trains (1–100 Hz) in the CPu in both genotypes ( p 0.05, two-
way ANOVA; 3 animals per genotype,). D, Mean profiles of [DA]o versus time (mean SEM)
after a single pulse (arrow) in the ventral striatum (NAc). There is no significant difference
between genotype in peak evoked [DA]o [p 0.05, one-way ANOVA; n 26 for both geno-
types (4 animals per genotype)]. E, F, Dopamine concentrations (nanograms per milligram of
protein) in the CPu andNAc dissected from the striatal sliceswere normalized to themean value
for wild-type animals in each brain structure (100%). Means SEM of data obtained from 8
wild-type (WT) and 11 triple-synuclein-nullmutant (///)mouse samples are
shown (*p 0.05; Kolmogorov–Smirnov test).
Figure 5. Regulation of dopamine signaling by cholinergic input, calcium, and uptake prob-
ability are similar in the CPu of wild-type and triple-synuclein-null mutant mice. A, B, Mean
peak [DA]o SEM versus frequency during five-pulse trains (1–100 Hz) in the dorsal striatum
of wild-type (A) and TKO (B) mice, with and without inhibition of nAChRs (using DHE). Data
are normalized to [DA]o under control conditions (***p 0.001, two-way ANOVA; 3 animals
per genotype). C, Response ofmeanpeak [DA]o evoked by a single pulse to varying extracellular
calcium concentrations (0.6– 4.8 mM) in CPu (in the presence of DHE) did not significantly
differ between genotypes ( p 0.05, two-way ANOVA; 4 animals per genotype). Data for each
genotype are normalized to mean peak [DA]o released at 4.8 mM Ca
2. Ratio of release by a
four-pulse burst (100Hz) versus a single pulse (4p:1p, right hand y-axis) as a function of calcium
concentration for both genotypes ( p 0.05, two-way ANOVA; 4 animals per genotype). D,
Comparison of the rates of decay of concentration-matched dopamine transients suggests that
dopamine uptake rates are not significantly different between the two genotypes ( p 0.05,
two-way ANOVA; n 8 for wild-type and n 7 for mutant mice).
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phenotype associated with a greater real-
izability but unchanged reuptake of this
neurotransmitter.
Additional data confirm that presyn-
aptic dopamine stores are reduced in the
striatum of mutant mice and also argue
against a hypothesis of upregulation of
postsynaptic transduction mechanisms
rather than enhanced presynaptic dopa-
mine releasability. We found that injec-
tion of 4 mg/kg dAMPH, which displaces
dopamine stored in synaptic vesicles into
extracellular space and whose effects de-
pend on the size of presynaptic dopamine
stores, but not regulated exocytosis, stim-
ulated locomotor activity of TKOmice to
a lesser and slower extent than of wild-
type (Fig. 6A,B) or single-synuclein-KO
mice (our unpublished data), whereas this
activity was significantly greater in mu-
tants when animals were first placed in a
novel nonanxiogenic environment. In
contrast, the locomotor response of TKO
mice to injection of 10 mg/kg cocaine,
which blocks dopamine uptake but does
not induce reverse transport of dopamine
from presynaptic terminal stores, was
similar to wild-type mice (Fig. 6C). The
difference in the effect of dAMPH and
cocaine on TKO mice supports the hy-
pothesis that dopaminergic presynaptic
terminals of these mice have reduced lev-
els of the neurotransmitter stored in syn-
aptic vesicles. Notably, boosting of
presynaptic dopamine storage by injec-
tion of 50 mg/kg methyl L-DOPA 20 min
before placing animal in a novel nonanx-
iogenic environment did not change the
behavior of TKO mice before amphetamine injection but re-
stored the level of their dAMPH-induced locomotor activity to
the level of wild-type mice (Fig. 6B).
Direct activation of postsynaptic D1/D2 dopamine receptors by
apomorphine (APO) shows that a transiently induced characteris-
tic “climbing” behavior (Protais et al., 1976)was slightly lessmarked
in TKOmice than inwild-typemice (Fig. 6D), suggesting that post-
synaptic dopamine signaling is in fact modestly attenuated in the
absence of synucleins, which is similar to other mouse lines with a
hyperdopaminergic phenotypes and probably represent mecha-
nisms inwhich downregulation of postsynaptic D1/D2 heterorecep-
tors compensates for increased levels of dopamine in the synaptic
cleft (Zhuang et al., 2001). This result further supports the hypoth-
esis that presynaptic mechanisms are responsible for the hyperdop-
aminergic phenotype of TKOmice.
No gross ultrastructural changes of striatal dopaminergic
axons in TKO mice
Quantitative electron-microscopic analyses of dopaminergic
profiles in the dorsal striatum of TKO and wild-type mice per-
formed on sections immunostained for TH using two techniques
(Fig. 7A,B) indicated the overall density of TH-positive profiles,
the number of mitochondria per structure and synaptic inci-
dence, were not different between two genotypes. Analysis of all
TH-immunogold profiles, as well as the subgroup forming syn-
aptic specializations, showed trends toward reduction in some
parameters in TKOmice, such as the cross-sectional area of TH-
positive profiles (18.6% smaller in all profiles; 35.6% smaller in
synapse-forming profiles), the number of synaptic vesicles per
profile (6.2 and 38.5% less), and also in the average distance of a
synaptic vesicle from the plasma membrane (5.2 and 14.4%
smaller) (Fig. 7D), but trends toward opposite outcomes in all
versus synapse-forming structures for other parameters, for ex-
ample, for the density of vesicles (9.5% increase across all versus
14.3% decrease in synapse-forming) and the average intervesicle
distance, an indication of clustering [24.8% decrease (Fig. 7C) vs
3.0% increase]. In TH-immunogold profiles that formed syn-
apses, the average distance of vesicles to the active zone was
smaller in the mutant animals (22.4% decreased) (Fig. 7D).
However, differences in these or other studied parameters
[data are available (see Notes)] were not statistically signifi-
cant, suggesting that the ultrastructure of dopaminergic syn-
apses in the striatum is not substantially affected by the
absence of synucleins.
Normal abundance of SNARE complexes in the dorsal
striatum of TKO mice
Recent in vivo studies demonstrated that synucleins might regu-
late neurotransmitter release by regulating synaptic SNARE com-
plex assembly and/or distribution of SNARE proteins within
synapses (Chandra et al., 2005; Burre´ et al., 2010; Garcia-
Figure 6. Behavior of wild-type and triple-synuclein-null mutant mice after pharmacological challenging of dopamine
neurotransmission. The locomotor activity (A–C) or climbing behavior (D) of wild-type (WT) (white diamonds) and TKO (/
//) (gray squares). A, Animals were injected with 4 mg/kg dAMPH after monitoring of their activity in novel environ-
ment (nonanxiogenic activity camera with infrared beams) for 30min and returned to the same camera for an additional 90min.
Statistically significant increase in the locomotor activity of mutant mice before treatment and decrease after treatment was
observed. B, A graph showing locomotor activity of triple-synuclein-null mutant mice pretreated with 50 mg/kg L-DOPA 20 min
before placing in the activity camera and consequent injecting dAMPH (black circles) overlays the same graphs as inA. Statistically
significant difference in the locomotor activity of wild-type and L-DOPA-pretreated mice (*) or naive and L-DOPA-pretreated
mutant mice ( #) is shown. C, The same protocol as described for Awas used to assess locomotion of mice treated with 10 mg/kg
cocaine. For all panels, statistically significant difference between two groups is shown for each 4 min interval (** ,##p 0.01;
*p 0.05; Kolmogorov–Smirnov test). D, Scoring of climbing behavior of mice after injection with 4 mg/kg APO was performed
as described in Materials and Methods.
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Reitbo¨ck et al., 2010). Analysis of total brain lysates revealed at-
tenuated assembly of SNARE complexes in TKOmice, whichwas
mirrored by a positive effect of-synuclein overexpressionon this
process in cultured hippocampal neurons (Burre´ et al., 2010). In
contrast, accumulation of -synuclein in striatal dopaminergic ter-
minals of transgenic mice resulted in reduced dopamine release
(Garcia-Reitbo¨ck et al., 2010). Overall, no uniform pattern emerges
from these studies, suggesting that different types of synapses may
respond differently to changes in synucleins availability. To reveal
whether the absence of synucleins affects SNARE complex assembly
in the dorsal striatum, we quantified the amount of vSNARE (vesic-
ular SNARE) VAMP2/synaptobrevin coimmunoprecipitated
with tSNARE (target membrane-associated SNARE) SNAP-25
from the lysates of freshly dissected dorsal striatum tissue and found
no difference between wild-type and TKO animals (Fig. 8).We also
observed no changes in distribution of SNAP-25 or CSP, a cochap-
erone of SNARE complex assembly, in the striatum of TKO mice
[data are available (see Notes)].
Discussion
The presynaptic functions of synucleins have been intensively
explored in many neuron types, including in recent studies using
TKO mice (Burre´ et al., 2010; Greten-Harrison et al., 2010), but
surprisingly, their functions at dopamine release sites have re-
mained poorly defined. Yet it may be imperative to understand
synuclein biology within dopaminergic neurons if we are to learn
how synuclein pathology is associated with the preferential de-
generation of these neurons in PD.Here, we show that deletion of
all three members of the synuclein family
significantly modifies the function of
some mesostriatal dopaminergic systems
but not others. Dopamine release from
dorsal striatal axons was greater in the
absence of synucleins, and TKO mice ex-
hibited hyperdopamine-like behaviors,
despite lower dopamine content and no
detectable disturbances in dopamine syn-
thesis, neuron number, availability of ves-
icles, or SNARE complex formation.
Furthermore, the neurochemical changes
in dopaminergic synapse function were
not detected in ventral striatum, indicat-
ing that synucleins differently govern do-
pamine transmission in nigrostriatal
compared with mesolimbic neurons.
These data suggest that synucleins limit
vesicular dopamine transmission through
mechanisms that differ from those re-
ported in other neurons and, further-
more, reveal key differences that vary with
dopaminergic neuron subtype.
Modifications to presynaptic dopamine
neurochemistry but not structure
Dopaminergic neurons in wild-type mice
express all threemembers of the synuclein
family. Data drawn from across our study
indicate that many aspects of mesostriatal
dopaminergic neuron biology do not dif-
fer between TKO and wild-type mice. We
show normal numbers of dopaminergic
neurons in SNpc andVTA, normal striatal
abundance and distribution of specific
proteins markers, and no difference in the
ultrastructure of dopaminergic synapses or vesicle distribution.
By contrast, our analysis of dopamine neurochemistry and
transmission as well as our behavioral analysis revealed signifi-
cant effects of synuclein depletion on mesostriatal function. De-
spite normal level of TH activity, dopamine content was 40%
lower in dorsal striatum of TKO than wild-type mice, a deficit
muchmoremarked than reported for double-/-synuclein-KO
mice (Chandra et al., 2004) or a line of -synuclein-KO mice on
a mixed genetic background (Abeliovich et al., 2000). No deficit
was detected in double-/-synuclein-KO (Robertson et al.,
2004; Senior et al., 2008) or/-synuclein-KOmice (our unpub-
lished data) on a pure C57BL/6J genetic background, and only in
aged (2 years) -synuclein-KO mice does striatal dopamine
content decline to a level comparable with that seen here in adult
TKO mice (Al-Wandi et al., 2010). These observations indicate
that all three synucleins are involved in dopamine regulation and
that, although elimination of each family member can be at least
partially or temporarily compensated for, loss of all three sy-
nucleins results in the greatest reduction in the capacity of syn-
apses to store dopamine. In conjunction with our EM data that
vesicle number is not modified, the reduced tissue dopamine
content suggests that, in TKO mice, less dopamine is stored per
vesicle.
The levels of dopamine metabolites DOPAC and HVA in
TKOmice were reduced to a lesser extent than dopamine, result-
ing in highermetabolite/dopamine ratios. This ratio is often used
to indicate that a greater percentage of dopamine is turned over
Figure 7. Electron-microscopic analyses of dopaminergic structures within the dorsal striatum in wild-type and triple-
synuclein-null mutant mice. Electron micrographs of TH-immunoreactive synaptic boutons in the dorsolateral striatum of a TKO
mouse. The immunoreactivity was revealed by the peroxidase method with diaminobenzidine as the chromogen (A) or the
immunogold method (B). The bouton forms symmetrical synaptic contact (arrowheads) with a dendritic shaft (d). Note the
nonimmunoreactive terminals forming an asymmetrical synaptic contact (white arrowheads) with a spine. Scale bars, 0.5m. C,
Frequency distribution of the intervesicle distances in immunogold-labeled TH-positive structures (150 TH-immunoreactive pro-
files from 3 animals per genotype). D, Frequency distribution of the distances of vesicles from the active zone in immunogold-
labeled TH-positive profiles that formed synaptic specializations (23 TH-immunoreactive synaptic boutons from 3 animals per
genotype).
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or, in other words, is released from vesicular stores with access to
extracellular and cytosolic metabolic pathways. Indeed, direct
study of dopamine release using FCV revealed a striking elevation
of the releasability of dopamine in the striatum in TKO mice.
This increase was not caused by a reduction in dopamine uptake
rate, an upregulation of nicotinic acetylcholine receptor func-
tion, or by increased sensitivity of the presynaptic exocytotic ma-
chinery to calcium or increased dopamine release probability [as
determined by measurements of frequency sensitivity, which
should be inversely correlated with release probability (Rice and
Cragg, 2004)]. Rather, the data suggest a generalized increase in
dopamine releasability per stimulus. Behavioral tests also sug-
gested that TKO mice had increased rather than decreased levels
of striatal dopamine. Furthermore, the experiments with a
dopamine-releasing agent (amphetamine) and a receptor ligand
(apomorphine) were in agreement with enhanced presynaptic
dopamine release despite reduced dopamine storage, and not
with any additional apparent upregulation of postsynaptic recep-
tor number or efficacy.
Several mechanisms, which are not mutually exclusive, can
underlie enhanced releasability from presynaptic terminals with
diminished content of the neurotransmitter. For example, neu-
rotransmitter releasability can be elevated if the recycling, readily
releasable pool of these vesicles is increased at the expense of the
reserve pool. Increased expression of -synuclein in cultured
hippocampal neurons reduces the size of the recycling pool and
can thus inhibit synaptic vesicle exocytosis (Nemani et al., 2010;
Scott et al., 2010). However, striatal dopaminergic synapses are
morphologically and functionally distinct from these synapses:
they lack spatially defined clusters of reserve and recycling vesi-
cles. Our ultrastructural analyses indicated that the presynaptic
distribution of synaptic vesicles in dorsal striatum is notmodified
in TKOmice, suggesting that synucleins do not regulate the over-
all anatomical distribution of vesicles within dopaminergic ax-
ons, unlike in other axon types, and that this does not explain a
change in dopamine releasability in TKO mice.
Another possible explanation for enhanced neurotransmitter
releasability is increased rate of vesicle fusion. However, such an
assumption is inconsistent with the recently obtained evidence
that in hippocampal neurons -synuclein promotes activity-
dependent assembly of SNARE complexes (Chandra et al., 2005;
Burre´ et al., 2010), which is a crucial step in the vesicle fusion
cycle. Moreover, we demonstrate here that, in dorsal striatum,
the abundance of SNARE complexes is not different in TKO and
wild-type mice. Therefore, it is unlikely that increased releasabil-
ity of dopamine in the absence of synucleins is caused by modi-
fied levels of SNARE complexes with consequent acceleration of
vesicle fusion.
It remains feasible that the presence or absence of synucleins
might affect formation of a fusion pore and thus the fate of a fused
vesicle (i.e., kiss-and-run or full-collapse fusion with the presyn-
aptic plasmamembrane). A boost in dopamine release could thus
arise from the release of a greater proportion of contents of each
vesicle or the number of dopamine quanta released per stimulus.
Additional detailed studies are required to test this hypothesis
and understand whether and why any of thesemechanisms differ
in nigrostriatal compared with mesolimbic neurons. We cannot
entirely exclude the possibility that changes to dopamine release
in the absence of synucleins reflect consequences of the develop-
mental compensation of the nigrostriatal neurons for the absence
of synucleins.
These data together suggest that, in the absence of synucleins,
dopamine axons release more vesicles (or more content of each
vesicle), each of which has a decreased dopamine load. The most
parsimonious explanation for reduced dopamine content of each
vesicle could be a downregulation in response to a gain in releas-
ability: indeed content is lower when extracellular availability of
dopamine is increased in other models (e.g., DAT-KO mice)
(Jones et al., 1998). However, differences in dopamine releasabil-
ity have been reported without complementary reductions in do-
pamine content in striatal terminals of/-synuclein double-KO
mice (Senior et al., 2008). Therefore, it is feasible that multiple
synuclein-dependent mechanisms might differently upregulate
releasability on the one hand and disrupt dopamine storage on
the other (e.g., compromise VMAT2 function, which in turn
downregulates dopamine content).
Regionally distinct effects of synuclein deletion: nigrostriatal
versus mesolimbic dopamine synapses
It is striking that synuclein depletion affects presynaptic dopa-
mine neurochemistry only in dorsal and not ventral striatum.
Thus, the roles of synucleins that we have described here in do-
paminergic neurons may differ substantially between neurons of
different neurotransmitter type (e.g., dopaminergic vs hippocampal
glutamatergic neurons) and, moreover, may be specific to neuron
subtype even for a given transmitter. Furthermore, since dopami-
nergic neurons innervating the dorsal striatum (nigrostriatal path-
way) degenerate in preference to those innervating the ventral
striatum (mesolimbic pathway) in PD, our findingmay offer signif-
Figure 8. Quantification of SNARE complexes in the dorsal striatum of wild-type and triple-
synuclein-null mutant mice. Coimmunoprecipitation of VAMP2/synaptobrevin with SNAP-25
was used to assess the abundance of SNARE complexes in the dorsal striatum ofwild-type (WT)
and TKO (///)mice. The bar chart shows amount of VAMP2/synaptobrevin in
SNAP-25 immunoprecipitates normalized to the amount of precipitated SNAP-25 and ex-
pressed as percentage of mean amount WT samples (SEM; results of 3 independent experi-
ments; 3WT and 3 TKOmice used in each of these experiments). A representativeWestern blots
shows results of analysis of two independent pairs of WT and TKO mice.
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icant new insight into the preferential degeneration seen in PD. Al-
though striking, the finding that amechanism regulating dopamine
neurotransmission might differ in nigrostriatal versus mesolimbic
neurons is not entirely unsurprising. A large body of work suggests
that nigrostriatal neurons differ frommesolimbic neurons in many
features [e.g., embryonic source and stage of ontogenetic develop-
ment, neuroanatomy of projections and inputs, proteins expression
levels including dopamine cell markers (DAT, VMAT2, D2 recep-
tors), ion channels and other proteins, influence of neuromodula-
tory receptors as well as the regulation of dopamine release
probability and their susceptibility to neurodegeneration (for re-
view, see Korotkova et al., 2004; Bjo¨rklund and Dunnett, 2007; Liss
and Roeper, 2008)]. Synuclein functionmay be another key feature
that variably influences the functionofnigrostriatal versusmesolim-
bic neurons.
Conclusions
These data significantly revise our understanding of synuclein
function. They indicate that synucleins in some dopaminergic
neurons limit synaptic neurotransmission through mechanisms
that differ from those reported in other neurons, which have
included vesicle pool redistribution or SNARE complex forma-
tion. These data shed light on the distinct role of synucleins in
dopaminergic neurons and reveal type-specific differences be-
tween dopaminergic neurons, whichmay ultimately offer insight
into the preferential degeneration of neurons subsets in PD.
Notes
Supplemental Figures S1–S5 and supplemental Tables 1–4 for this article
are available at https://docs.google.com/viewer?av&pidexplorer&
chrometrue&srcid0B-2G31EgcACfZjRjZDFjZTEtNGRlZi00ODI2L
Tg2NWUtOWYyYzQ4YzA2OGUx&hlen. This material has not been
peer reviewed.
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